Table of Contents

1 Industry Overview

• 1.1 Autologous Cell Therapy Industry
  • 1.1.1 Overview
  • 1.1.2 Development of Autologous Cell Therapy
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 Autologous Cell Therapy Market by Type

• 3.1 By Type
  • 3.1.1 Bone Marrow
  • 3.1.2 Epidermis
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.Autologous Cell Therapy BioTime, Inc. (Company Profile, Sales Data etc.)

• 4.2 BrainStorm Cell Therapeutics (Company Profile, Sales Data etc.)
• 4.3 Caladrius Biosciences, Inc. (Company Profile, Sales Data etc.)
• 4.4 Fibrocell Science, Inc. (Company Profile, Sales Data etc.)
• 4.5 Opexa Therapeutics, Inc. (Company Profile, Sales Data etc.)
• 4.6 Pharmicell Co., Inc. (Company Profile, Sales Data etc.)
• 4.7 Regeneus Ltd. (Company Profile, Sales Data etc.)
• 4.8 TiGenix NV (Company Profile, Sales Data etc.)
• 4.9 TxCell SA (Company Profile, Sales Data etc.)
• 4.10 U.S. Stem Cell, Inc. (Company Profile, Sales Data etc.)
• 4.11 Vericel Corporation (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Neurology
  • 6.1.2 Demand in Orthopedics
  • 6.1.3 Demand in Cancer
  • 6.1.4 Demand in Wound Healing
  • 6.1.5 Demand in CVD
  • 6.1.6 Demand in Autoimmune
  • 6.1.7 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of Autologous Cell Therapy

Table Application Segment of Autologous Cell Therapy

Table Global Autologous Cell Therapy Market 2013-2024, by Application, in USD Million

Table Major Company List of Bone Marrow

Table Major Company List of Epidermis

Table Global Autologous Cell Therapy Market 2013-2018, by Type, in USD Million

Table Global Autologous Cell Therapy Market 2013-2018, by Type, in Volume

Table Global Autologous Cell Therapy Market Forecast 2019-2024, by Type, in USD Million

Table Global Autologous Cell Therapy Market Forecast 2019-2024, by Type, in Volume

Table BioTime, Inc. Overview List

Table Autologous Cell Therapy Business Operation of BioTime, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table BrainStorm Cell Therapeutics Overview List

Table Autologous Cell Therapy Business Operation of BrainStorm Cell Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Caladrius Biosciences, Inc. Overview List

Table Autologous Cell Therapy Business Operation of Caladrius Biosciences, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Fibrocell Science, Inc. Overview List

Table Autologous Cell Therapy Business Operation of Fibrocell Science, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Opexa Therapeutics, Inc. Overview List

Table Autologous Cell Therapy Business Operation of Opexa Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pharmicell Co., Inc. Overview List

Table Autologous Cell Therapy Business Operation of Pharmicell Co., Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Regeneus Ltd. Overview List

Table Autologous Cell Therapy Business Operation of Regeneus Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table TiGenix NV Overview List

Table Autologous Cell Therapy Business Operation of TiGenix NV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table TxCell SA Overview List

Table Autologous Cell Therapy Business Operation of TxCell SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table U.S. Stem Cell, Inc. Overview List

Table Autologous Cell Therapy Business Operation of U.S. Stem Cell, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Vericel Corporation Overview List

Table Autologous Cell Therapy Business Operation of Vericel Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global Autologous Cell Therapy Sales Revenue 2013-2018, by Company, in USD Million

Table Global Autologous Cell Therapy Sales Revenue Share, by Company, in USD Million

Table Global Autologous Cell Therapy Sales Volume 2013-2018, by Company, in Volume

Table Global Autologous Cell Therapy Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table Autologous Cell Therapy Demand Forecast 2019-2024, by Application, in USD Million

Table Autologous Cell Therapy Demand Forecast 2019-2024, by Application, in Volume

Table Autologous Cell Therapy Production 2013-2018, by Region, in USD Million

Table Autologous Cell Therapy Production 2013-2018, by Region, in Volume

Table Global Autologous Cell Therapy Market 2013-2018, by Region, in USD Million

Table Global Autologous Cell Therapy Market Share 2013-2018, by Region, in USD Million

Table Global Autologous Cell Therapy Market 2013-2018, by Region, in Volume

Table Global Autologous Cell Therapy Market Share 2013-2018, by Region, in Volume

Table North America Autologous Cell Therapy Market Size 2013-2018, by Country, in USD Million

Table North America Autologous Cell Therapy Market Size 2013-2018, by Country, in Volume

Table Europe Autologous Cell Therapy Market Size 2013-2018, by Country, in USD Million

Table Europe Autologous Cell Therapy Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific Autologous Cell Therapy Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific Autologous Cell Therapy Market Size 2013-2018, by Country, in Volume

Table South America Autologous Cell Therapy Market Size 2013-2018, by Country, in USD Million

Table South America Autologous Cell Therapy Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa Autologous Cell Therapy Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa Autologous Cell Therapy Market Size 2013-2018, by Country, in Volume

Table Autologous Cell Therapy Market Forecast 2019-2024, by Region, in USD Million

Table Autologous Cell Therapy Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global Autologous Cell Therapy Market Growth 2013-2018, by Type, in USD Million

Figure Global Autologous Cell Therapy Market Growth 2013-2018, by Type, in Volume

Figure North America Autologous Cell Therapy Market Concentration, in 2018

Figure Europe Autologous Cell Therapy Market Market Concentration, in 2018

Figure Asia-Pacific Autologous Cell Therapy MMarket Concentration, in 2018

Figure South America Autologous Cell Therapy Market Concentration, in 2018

Figure Middle East & Africa Autologous Cell Therapy Market Concentration, in 2018

Figure Autologous Cell Therapy Demand in Neurology , 2013-2018, in USD Million

Figure Autologous Cell Therapy Demand in Neurology , 2013-2018, in Volume

Figure Autologous Cell Therapy Demand in Orthopedics , 2013-2018, in USD Million

Figure Autologous Cell Therapy Demand in Orthopedics , 2013-2018, in Volume

Figure Autologous Cell Therapy Demand in Cancer , 2013-2018, in USD Million

Figure Autologous Cell Therapy Demand in Cancer , 2013-2018, in Volume

Figure Autologous Cell Therapy Demand in Wound Healing , 2013-2018, in USD Million

Figure Autologous Cell Therapy Demand in Wound Healing , 2013-2018, in Volume

Figure Autologous Cell Therapy Demand in CVD , 2013-2018, in USD Million

Figure Autologous Cell Therapy Demand in CVD , 2013-2018, in Volume

Figure Autologous Cell Therapy Demand in Autoimmune , 2013-2018, in USD Million

Figure Autologous Cell Therapy Demand in Autoimmune , 2013-2018, in Volume

Figure Autologous Cell Therapy Demand in Others, 2013-2018, in USD Million

Figure Autologous Cell Therapy Demand in Others, 2013-2018, in Volume

Figure North America Autologous Cell Therapy Market Size and Growth 2013-2018, in USD Million

Figure North America Autologous Cell Therapy Market Size and Growth 2013-2018, in Volume

Figure Europe Autologous Cell Therapy Market Size and Growth 2013-2018, in USD Million

Figure Europe Autologous Cell Therapy Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific Autologous Cell Therapy Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific Autologous Cell Therapy Market Size and Growth 2013-2018, in Volume

Figure South America Autologous Cell Therapy Market Size and Growth 2013-2018, in USD Million

Figure South America Autologous Cell Therapy Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa Autologous Cell Therapy Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa Autologous Cell Therapy Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview

Snapshot
The global Autologous Cell Therapy market will reach xxx Million USD in 2019 and CAGR xx% 2019-2024. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Autologous Cell Therapy by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Bone Marrow 
Epidermis
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
BioTime, Inc. 
BrainStorm Cell Therapeutics 
Caladrius Biosciences, Inc. 
Fibrocell Science, Inc. 
Opexa Therapeutics, Inc. 
Pharmicell Co., Inc. 
Regeneus Ltd. 
TiGenix NV 
TxCell SA 
U.S. Stem Cell, Inc. 
Vericel Corporation
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Neurology 
Orthopedics 
Cancer 
Wound Healing 
CVD 
Autoimmune 
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)